Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Effect of Smart Watch and App on PAP Adherence in OSA (Watch-OSA)

NCT: NCT05530265 · COMPLETED

NCT IDNCT05530265
StatusCOMPLETED
Start Date2022-08-22
Completion2025-04-14

Brief Summary

Continuous positive airway pressure (CPAP) is highly effective in treating obstructive sleep apnea (OSA). However, this treatment modality relies heavily on patient adherence, and poor adherence to the treatment limits its effectiveness in treating OSA. Strategies to augment adherence are needed in the management of OSA. The smart watch and linked app provide various health information, including sleep, snoring or oxygen saturation during sleep, exercise, blood pressure, and electrocardiogram. The smart watch and linked app could potentially improve adherence to positive airway pressure (PAP) treatment. This randomized controlled trial (RCT) aimed to examine whether the use of smart watch and app can increase PAP adherence in patients with OSA.

Frequently Asked Questions

What is Effect of Smart Watch and App on PAP Adherence in OSA (Watch-OSA)?

Effect of Smart Watch and App on PAP Adherence in OSA (Watch-OSA) is a clinical trial registered under NCT05530265. Current status: COMPLETED.

What is the status of NCT05530265?

The current status of NCT05530265 (Effect of Smart Watch and App on PAP Adherence in OSA (Watch-OSA)) is: COMPLETED.

When did Effect of Smart Watch and App on PAP Adherence in OSA (Watch-OSA) start?

Effect of Smart Watch and App on PAP Adherence in OSA (Watch-OSA) started on 2022-08-22.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.